Last updated on November 2017

Phase 2, Multi-center, Randomized, Double-blind, Placebocontrolled Study to Evaluate the Efficacy and Safety of Brilacidin Oral Rinse Administered Daily for 7 Weeks in Attenuating Oral Mucositis in Patients with Head and Neck Cancer Receiving Concurrent Chemotherapy and Radiotherapy


Brief description of study

Phase 2, Multi-center, Randomized, Double-blind, Placebocontrolled Study to Evaluate the Efficacy and Safety of Brilacidin Oral Rinse Administered Daily for 7 Weeks in Attenuating Oral Mucositis in Patients with Head and Neck Cancer Receiving Concurrent Chemotherapy and Radiotherapy

Detailed Study Description

Prevention of oral mucositis induced by chemoradiation regimens used for the treatment of cancers of the head and neck.

Clinical Study Identifier: TX82125

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Research Center

Columbus Regional Research Institute
Columbus, GA USA
  Connect »